… Roflumilast, a promising therapeutic approach in inflammatory airway … roflumilast in COPD
and asthma. However, there is no published clinical evidence to date for the role of roflumilast …

… and related findings in chronic obstructive pulmonary disease (COPD). The … drugs such
as roflumilast have an excellent safety profile and efficacy in patients with asthma and COPD. …

… treatment discontinuation resulting from the use of an uptitration regimen in patients with …
COPD who initiate therapy with roflumilast. Pharmacists have a central role in effective COPD …

… The results of this study were consistent with those obtained with roflumilast in asthma patients
where a significant attenuation of LAR and other mediators was also observed (Bardin et …

… This study evaluated the efficacy and safety of roflumilast in patients with moderate to severe
COPD using RCT data in combination with inhaled ICS/LABA. The results suggested that …

… This article will discuss the evidence of roflumilast and other PDE4 inhibitors for treating …
roflumilast to COPD standard treatment. The evidence of roflumilast in the treatment of COPD …

… roflumilast across all age groups, smoking status and geographic regions [Citation26]. A
Cochrane database systematic revealed that roflumilast … add-on benefit of roflumilast to patients …

… Background: Roflumilast is an option for treating patients with severe COPD and frequent …
(PDE) 4 inhibitor roflumilast and its active metabolite roflumilast N-oxide affect the release of …

… The efficacy of Roflumilast can prevent exacerbations of … Roflumilast is better than the group
without additional. This paper aimed to review systematically Roflumilast as COPD treatment …

… in the treatment of COPD and asthma. The … asthma treatment, oral roflumilast has been
proposed as a beneficial add-on therapy for use in patients with moderate-to-severe asthma …